DOCSLIB.ORG

Peroxisome Proliferator-Activated Receptor ; and Retinoid X Receptor Ligands Are Potent Inducers of Differentiation and Apoptosis in Leukemias

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Peroxisome Proliferator-Activated Receptor ; and Retinoid X Receptor Ligands Are Potent Inducers of Differentiation and Apoptosis in Leukemias Molecular Cancer Therapeutics 1249 Peroxisome proliferator-activated receptor ; and retinoid X receptor ligands are potent inducers of differentiation and apoptosis in leukemias Marina Konopleva,1 Elena Elstner,4 (i.e., all trans-retinoic acid) enhanced differentiating and Teresa J. McQueen,1 Twee Tsao,1 growth-inhibitory effects. 2-Cyano-3,12-dioxooleana-1,9- Andrey Sudarikov,1 Wei Hu,1 Wendy D. Schober,1 dien-28-oic acid induced differentiation and apoptosis Rui-Yu Wang,1 David Chism,1 Steven M. Kornblau,1 with much greater potency than the other PPAR; ligands Anas Younes,2 Steven J. Collins,5 H. Phillip Koeffler,6 in established cell lines and primary chronic lymphocytic and Michael Andreeff1,3 leukemia samples. Exposure to 2-cyano-3,12-dioxo- oleana-1,9-dien-28-oic acid induced mitochondrial depo- Section of Molecular Hematology and Therapy and Departments larization and caspase activation, which was associated of 1Blood and Marrow Transplantation, 2Lymphoma, and 3Leukemia, University of Texas M.D. Anderson Cancer Center, with apoptosis induction. In Bcl-2-overexpressing chronic Houston, Texas; 4Department of Medicine (Charite´), Division lymphocytic leukemia cells, the small-molecule Bcl-2 of Hematology/Oncology, Humboldt University, Berlin, Germany; inhibitor HA14-1 sensitized these cells to 2-cyano-3,12- 5Fred Hutchinson Cancer Research Center, Seattle, Washington; 6 dioxooleana-1,9-dien-28-oic acid–induced apoptosis. and Division of Hematology/Oncology, Cedars-Sinai Medical ; Center/University of California at Los Angeles School of Medicine, These results suggest that PPAR ligation alone and in Los Angeles, California combination with retinoids holds promise as novel therapy for leukemias by activating the transcriptional activity of target genes that control apoptosis and differentiation in Abstract leukemias. [Mol Cancer Ther 2004;3(10):1249–62] The peroxisome proliferator-activated receptor ; (PPAR;) is a member of the nuclear receptor family that forms heterodimers with retinoid X receptor. These heterodimers Introduction bind to DNA and activate the transcription of target genes. Recent progress in the molecular and cellular biology of the Here, we report that the PPAR; receptor protein is nuclear steroid receptor superfamily has identified certain expressed in primary myeloid and lymphoid leukemias members as molecular targets for cancer therapy (1). They and in lymphoma and myeloma cell lines. In this study, we include estrogen receptors, retinoic acid receptors, retinoid compared the activity of several PPAR; ligands including X receptors (RXR; the RXR-specific ligands are termed BRL49653 (rosiglitazone), 15-deoxy-#12,14-prostaglan- ‘‘rexinoids’’), and the vitamin D receptor (the vitamin D– specific ligands are termed ‘‘deltanoids’’). These nuclear din J2, and the novel triterpenoid 2-cyano-3,12-dioxo- oleana-1,9-dien-28-oic acid on leukemia cells. Exposure to receptors are putative cancer therapy targets because they these PPAR; ligands induced apoptosis in myeloid (U937 function as transcription factors that control the expression and HL-60) and lymphoid (Su-DHL, Sup-M2, Ramos, Raji, of many genes related to cell differentiation (1, 2). The Hodgkin’s cell lines, and primary chronic lymphocytic strongest evidence for the therapeutic potential of this leukemia) cells. A similar exposure to these PPAR; ligands approach comes from the efficacy of retinoic acid receptor a induced the differentiation of myeloid leukemic cells. A activation in the treatment of acute promyelocytic leukemia combination of PPAR; ligands with a retinoid X receptor (3). Over 90% of patients with acute promyelocytic agonist (i.e., LG100268) or a retinoic acid receptor agonist leukemia achieve complete remission following treatment with the naturally occurring retinoid all trans-retinoic acid (ATRA; ref. 4). The peroxisome proliferator-activated receptor g (PPARg) is a recent addition to the nuclear steroid receptor Received 7/14/03; revised 7/2/04; accepted 7/22/04. superfamily that is believed to be involved in the regulation Grant support: Leukemia and Lymphoma Society (M. Konopleva), of lipid metabolism. Like other nuclear steroid receptors, National Cancer Institute grants RO1 CA89346 and 1 P50 CA100632-01, (M. Andreeff) Deutsche Forschungsgemeinschaft grant and J-Carreras the dysregulation of PPARg has been implicated in (E. Elstner). aberrant differentiation. PPARg is an important mediator The costs of publication of this article were defrayed in part by the of the differentiation of preadipocytes to adipocytes and is payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to a target in the treatment of diabetes, where receptor indicate this fact. activation increases sensitivity to endogenous insulin. To Requests for reprints: Michael Andreeff, Department of Blood and Marrow activate transcription, PPARg must form a heterodimer Transplantation, University of Texas M.D. Anderson Cancer Center, with RXRa (5). The PPARg/RXR heterodimers can then be 1515 Holcombe Boulevard, Unit 448, Houston, TX 77030. Phone: 713-792-7260; Fax: 713-794-4747. activated by the ligation of PPARg or RXR ligands (6), but E-mail: [email protected] the simultaneous ligation of both PPARg and RXR max- Copyright C 2004 American Association for Cancer Research. imizes their activation. PPARg can be activated by Mol Cancer Ther 2004;3(10). October 2004 Downloaded from mct.aacrjournals.org on September 24, 2021. © 2004 American Association for Cancer Research. 1250 PPARg and RXR Ligands in Leukemias naturally occurring ligands such as the long-chain fatty (27), a selective PPARg antagonist, was synthesized and acids 15-deoxy-D12,14-prostaglandin J2 (15-d-PGJ2) and 9- kindly provided by Dr. Stephen H. Safe (Texas A&M and 13-cis-hydroxyoctadecadienoic acid (7–9). They are University, College Station, TX). HA14-1 (ethyl 2-amino-6- also activated by synthetic ligands including the antidia- bromo-4-[1-cyano-2-ethoxy-2-oxoethyl]-4H-chromene-3- betic agents troglitazone, BRL49653 (rosiglitazone), and carboxylate), a novel nonpeptidic ligand of the Bcl-2 pioglitazone; L-Tyr-based PPARg ligands (10); Fmoc-L-Leu BH3-binding pocket (28, 29) that inhibits Bcl-2 function, was amino acids (11); and certain triterpenoids (12). kindly provided by Dr. Ziwei Huang (University of Illinois Although PPARg ligands have mainly been used for the at Urbana-Champaign, Urbana, IL). The Fas signaling anti- treatment of diabetes, they have also been shown to induce body CH11 was purchased from Immunotech (Miami, FL) lipogenic differentiation of malignant cells in vivo in and tumor necrosis factor–related apoptosis-inducing li- patients with liposarcomas (13). In hematopoiesis, PPARg gand (TRAIL) was purchased from Alexis (San Diego, CA). expression is increased during differentiation of monocytes Cell Lines to macrophages and the activation of PPARg/RXR-regu- HL-60, U937, Jurkat, Daudi, Raji, Ramos, 8226, and IM-9 lated genes induces macrophage differentiation (9). PPARg cell lines were obtained from the American Type Culture expression has been detected in human breast, lung, Collection (Rockville, MD). HL-60 is a myeloid leukemia bladder, colon, prostate, and pancreatic cancer cells and cell line; U937 is a monocytic leukemia cell line; Daudi, the ligand-induced activation of PPARg/RXR induced Ramos, and Raji are human Burkitt lymphoma cell lines; g apoptosis in these cell types (14–21). PPAR /RXR signal- Jurkat is a T-lymphoblast cell line; 8226 and IM-9 are ing is involved in the induction of apoptosis in T myeloma cell lines. The Sup-M2 and Su-DHL-1 cell lines lymphocytes (22) and myeloid leukemias (23). Interesting- were derived from CD30+ anaplastic large-cell lymphomas ly, a recent report showed that synthetic PPARg agonists and carry the t(2;5) chromosomal translocation (30). The used at high concentrations inhibited the translation human Hodgkin and Reed-Sternberg–derived cell lines initiation of eukaryotic initiation factor-2 by phosphoryla- HD-MYZ, HD-LM-2, L-428, and KM-H2 were provided by tion in PPARg-deficient embryonic stem cells, suggesting the German Collection of Microorganisms and Cell the existence of a receptor-independent antiproliferative Cultures (Braunschweig, Germany). The phenotypes and mechanism (24). genotypes of these cell lines have been published previ- In this study, we investigated the effects of structurally ously (31). The HL-60-derived subline CDM-1, which different PPARg ligands on a variety of myeloid and expresses low levels of PPARg, was kindly provided by lymphoid leukemic cell lines and primary leukemia Dr. Peter Davies (University of Texas, Houston, TX; ref. 23). g samples. The PPAR ligands decreased viability and Subjects induced apoptosis, with the novel triterpenoid 2-cyano- Bone marrow or peripheral blood samples were obtained 3,12-dioxooleana-1,9-dien-28-oic acid (CDDO) being the for in vitro studies from patients with chronic lymphocytic most potent cytotoxic agent. Concomitant RXRa ligation leukemia (CLL), acute lymphoblastic leukemia, and acute enhanced the effects of PPARg ligands and the combination myelogenous leukemia (AML). Samples were obtained of a PPARg ligand with ATRA induced maturation of during routine diagnostic procedures after informed myelomonocytic cells. Furthermore, the proapoptotic effects of CDDO could be further enhanced by inhibition consent was obtained in accordance with regulations and of Bcl-2. Hence, the apoptotic and differentiation-inducing
Load more

Recommended publications
  • Detailed Review Paper on Retinoid Pathway Signalling
    1 1 Detailed Review Paper on Retinoid Pathway Signalling 2 December 2020 3 2 4 Foreword 5 1. Project 4.97 to develop a Detailed Review Paper (DRP) on the Retinoid System 6 was added to the Test Guidelines Programme work plan in 2015. The project was 7 originally proposed by Sweden and the European Commission later joined the project as 8 a co-lead. In 2019, the OECD Secretariat was added to coordinate input from expert 9 consultants. The initial objectives of the project were to: 10 draft a review of the biology of retinoid signalling pathway, 11 describe retinoid-mediated effects on various organ systems, 12 identify relevant retinoid in vitro and ex vivo assays that measure mechanistic 13 effects of chemicals for development, and 14 Identify in vivo endpoints that could be added to existing test guidelines to 15 identify chemical effects on retinoid pathway signalling. 16 2. This DRP is intended to expand the recommendations for the retinoid pathway 17 included in the OECD Detailed Review Paper on the State of the Science on Novel In 18 vitro and In vivo Screening and Testing Methods and Endpoints for Evaluating 19 Endocrine Disruptors (DRP No 178). The retinoid signalling pathway was one of seven 20 endocrine pathways considered to be susceptible to environmental endocrine disruption 21 and for which relevant endpoints could be measured in new or existing OECD Test 22 Guidelines for evaluating endocrine disruption. Due to the complexity of retinoid 23 signalling across multiple organ systems, this effort was foreseen as a multi-step process.
    [Show full text]
  • Retinoid X Receptor'' B-Mediated TSLP Expression by Κ NF
    Comment on ''Cutting Edge: Inhibition of NF- κB-Mediated TSLP Expression by Retinoid X Receptor'' This information is current as Janine Gericke, Anat Gamlieli, Kathrin Weiss and Ralph of September 23, 2021. Rühl J Immunol 2009; 182:3; ; doi: 10.4049/jimmunol.182.1.3-a http://www.jimmunol.org/content/182/1/3.1 Downloaded from References This article cites 3 articles, 2 of which you can access for free at: http://www.jimmunol.org/content/182/1/3.1.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on September 23, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Letters to the Editor 2. Allenby, G., M. T. Saunders, M. Saunders, S. Kazmer, J. Speck, M. Rosenberger, A. Comment on “Cutting Edge: Lovey, P. Kastner, J. F. Grippo, P. Chambon, et al. 1993. Retinoic acid receptors and Inhibition of NF-␬B-Mediated retinoid X receptors: interactions with endogenous retinoic acids.
    [Show full text]
  • Pathway Development Via Retinoid X Receptor Vitamin a Enhances In
    Vitamin A Enhances in Vitro Th2 Development Via Retinoid X Receptor Pathway This information is current as Charles B. Stephensen, Reuven Rasooly, Xiaowen Jiang, of September 24, 2021. Michael A. Ceddia, Casey T. Weaver, Roshantha A. S. Chandraratna and R. Patterson Bucy J Immunol 2002; 168:4495-4503; ; doi: 10.4049/jimmunol.168.9.4495 http://www.jimmunol.org/content/168/9/4495 Downloaded from References This article cites 40 articles, 24 of which you can access for free at: http://www.jimmunol.org/content/168/9/4495.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on September 24, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2002 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Vitamin A Enhances in Vitro Th2 Development Via Retinoid X Receptor Pathway1 Charles B. Stephensen,2* Reuven Rasooly,* Xiaowen Jiang,* Michael A. Ceddia,3* Casey T. Weaver,† Roshantha A. S. Chandraratna,‡ and R. Patterson Bucy† Vitamin A deficiency diminishes Th2-mediated Ab responses, and high-level dietary vitamin A or treatment with the vitamin A metabolite retinoic acid (RA) enhances such responses.
    [Show full text]
  • Retinoic Acid-Related Orphan Receptor Rorβ, Circadian Rhythm Abnormalities and Tumorigenesis (Review)
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE 35: 1493-1500, 2015 Retinoic acid-related orphan receptor RORβ, circadian rhythm abnormalities and tumorigenesis (Review) SHUJIONG FENG1, SONG XU1, ZHENZHEN WEN1 and YONGLIANG ZHU1,2 1Laboratory of Gastroenterology, The Second Affiliated Hospital of Zhejiang University, School of Medicine; 2Cancer Institute and Education Ministry Key Laboratory of Cancer Prevention and Intervention, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310009, P.R. China Received August 8, 2014; Accepted March 12, 2015 DOI: 10.3892/ijmm.2015.2155 Abstract. Nuclear receptors are a superfamily of transcription and have important physiological functions in cell develop- factors including the steroid hormone receptors, non-steroid ment and differentiation, circadian rhythm, metabolism and hormone receptors and the orphan nuclear receptor family. immune regulation. NRs consist of three components: the Retinoic acid-related orphan receptor (ROR)β, as a member of steroid hormone receptors, non-steroid hormone receptors the orphan nuclear receptor family, plays an important regula- and the orphan nuclear receptor family. Steroid and non- tory role in the maintenance of a variety of physiological and steroid hormone receptors have specific ligands, including pathological processes. RORβ has been determined to act as steroid hormones, thyroid hormones, retinoic acids and fatty an osteogenic repressor in regulating bone formation, and is acids. Ligands for orphan NRs have not yet been determined. involved in regulating circadian rhythm. The findings of recent Retinoic acid-related orphan receptors (RORs), also known studies concerning the association between tumorigenesis as nuclear receptor subfamily 1 group F members (NR1F), and circadian rhythm have shown that an aberrant circadian are specified by gene sequences, which are homologous to rhythm may promote tumorigenesis and tumor progression.
    [Show full text]
  • Retinoid-Induced Apoptosis in Normal and Neoplastic Tissues
    Cell Death and Differentiation (1998) 5, 11 ± 19 1998 Stockton Press All rights reserved 13509047/98 $12.00 Review Retinoid-induced apoptosis in normal and neoplastic tissues Laszlo Nagy1,3,4, Vilmos A. Thomazy1, Richard A. Heyman2 retinoic acid receptor (RAR), which belongs to the superfamily and Peter J.A. Davies1,3 of ligand-activated transcription factors (nuclear receptors) revolutionized our understanding as to how retinoids exert 1 Department of Pharmacology, University of Texas-Houston, Medical School, their pleiotropic effects (for reviews see Chambon (1996); Houston, Texas 77225 USA Mangelsdorf et al (1994)). Members of the nuclear receptor 2 Ligand Pharmaceuticals, San Diego, California, 92121 USA superfamily mediate the biological effects of many hormones, 3 Corresponding author: PJAD, tel: 713-500-7480; fax: 713-500-7455; vitamins and drugs (i.e. steroid hormones, thyroid hormones, e-mail: [email protected] 4 vitamin D, prostaglandin-J (PG-J ) and drugs that activate Present address for correspondence: The Salk Institute for Biological Studies, 2 2 Gene Expression Laboratory, La Jolla, California 92037; peroxisomal proliferation). There are two families of retinoid tel: (619) 453-4100 fax:(619) 455-1349; e-mail: [email protected] receptors, Retinoid X Receptors (RXRs) that bind 9-cis retinoic acid (9-cis RA) and Retinoic Acid Receptors (RARs) Received 18.8.97; revised 19.9.97; accepted 22.9.97 that bind both 9-cis RA and all-trans retinoic acid (ATRA) (for Edited by M. Piacentini reviews see Chambon 1996; Mangelsdorf et al, 1994)). Each of these receptor families includes at least three distinct genes, (RARa,b and g; RXRa,b and g) that through differential Abstract promoter usage and alternative splicing, give rise to a large number of distinct retinoid receptor proteins (for reviews see Vitamin A and its derivatives (collectively referred to as Chambon 1996; Mangelsdorf et al, 1994).
    [Show full text]
  • Integrated Computational Approach to the Analysis of RNA-Seq Data Reveals New Transcriptional Regulators of Psoriasis
    OPEN Experimental & Molecular Medicine (2016) 48, e268; doi:10.1038/emm.2016.97 & 2016 KSBMB. All rights reserved 2092-6413/16 www.nature.com/emm ORIGINAL ARTICLE Integrated computational approach to the analysis of RNA-seq data reveals new transcriptional regulators of psoriasis Alena Zolotarenko1, Evgeny Chekalin1, Alexandre Mesentsev1, Ludmila Kiseleva2, Elena Gribanova2, Rohini Mehta3, Ancha Baranova3,4,5,6, Tatiana V Tatarinova6,7,8, Eleonora S Piruzian1 and Sergey Bruskin1,5 Psoriasis is a common inflammatory skin disease with complex etiology and chronic progression. To provide novel insights into the regulatory molecular mechanisms of the disease, we performed RNA sequencing analysis of 14 pairs of skin samples collected from patients with psoriasis. Subsequent pathway analysis and extraction of the transcriptional regulators governing psoriasis-associated pathways was executed using a combination of the MetaCore Interactome enrichment tool and the cisExpress algorithm, followed by comparison to a set of previously described psoriasis response elements. A comparative approach allowed us to identify 42 core transcriptional regulators of the disease associated with inflammation (NFκB, IRF9, JUN, FOS, SRF), the activity of T cells in psoriatic lesions (STAT6, FOXP3, NFATC2, GATA3, TCF7, RUNX1), the hyper- proliferation and migration of keratinocytes (JUN, FOS, NFIB, TFAP2A, TFAP2C) and lipid metabolism (TFAP2, RARA, VDR). In addition to the core regulators, we identified 38 transcription factors previously not associated with the disease that can clarify the pathogenesis of psoriasis. To illustrate these findings, we analyzed the regulatory role of one of the identified transcription factors (TFs), FOXA1. Using ChIP-seq and RNA-seq data, we concluded that the atypical expression of the FOXA1 TF is an important player in the disease as it inhibits the maturation of naive T cells into the (CD4+FOXA1+CD47+CD69+PD-L1(hi) FOXP3 − ) regulatory T cell subpopulation, therefore contributing to the development of psoriatic skin lesions.
    [Show full text]
  • Retinoid X Receptor Is Necessary to Establish the S-Opsin Gradient In
    Retinoid X Receptor ␥ Is Necessary to Establish the S-opsin Gradient in Cone Photoreceptors of the Developing Mouse Retina Melanie R. Roberts,1,2 Anita Hendrickson,2 Christopher R. McGuire,2 and Thomas A. Reh2 PURPOSE. The retinoid X receptors (RXRs) are members of the tion, they also have demonstrated some isoform-specific family of ligand-dependent nuclear hormone receptors. One of functions. For example, RXR␣ heterodimerizes with retinoic these genes, RXR␥, is expressed in highly restricted regions of acid receptors (RARs) to regulate retinal growth and cardiac the developing central nervous system (CNS), including the development.4 retina. Although previous studies have localized RXR␥ to de- Although all three isoforms are expressed in the developing veloping cone photoreceptors in several species, its function nervous system, RXR␥ has the most restricted and develop- in these cells is unknown. A prior study showed that thyroid mentally regulated expression. It is expressed in the develop- hormone receptor ␤2 (TR␤2) is necessary to establish proper ing striatum, part of the tegmentum, the pituitary, the ventral cone patterning in mice by activating medium-wavelength (M) horns of the spinal cord,3,5 and the retina.6 RXR␥-null mice cone opsin and suppressing short-wavelength (S) cone opsin. show isoform-specific defects in both striatal and hippocampal Thyroid hormone receptors often regulate gene transcription function, although RXR␤ can partially compensate for the loss as heterodimeric complexes with RXRs. of RXR␥ in the striatum.2,7,8 RXR␥ has also been identified in 6,9,10 METHODS. To determine whether RXR␥ cooperates with TR␤2 the developing retina of Xenopus, chicks, and mice.
    [Show full text]
  • Estrogen Modulates Transactivations of SXR-Mediated Liver X Receptor Response Element and CAR-Mediated Phenobarbital Response Element in Hepg2 Cells
    EXPERIMENTAL and MOLECULAR MEDICINE, Vol. 42, No. 11, 731-738, November 2010 Estrogen modulates transactivations of SXR-mediated liver X receptor response element and CAR-mediated phenobarbital response element in HepG2 cells Gyesik Min1 by moxestrol in the presence of ER. Thus, ER may play both stimulatory and inhibitory roles in modulating Department of Pharmaceutical Engineering CAR-mediated transactivation of PBRU depending on Jinju National University the presence of their ligands. In summary, this study Jinju 660-758, Korea demonstrates that estrogen modulates transcriptional 1Correspondence: Tel, 82-55-751-3396; activity of SXR and CAR in mediating transactivation Fax, 82-55-751-3399; E-mail, [email protected] of LXRE and PBRU, respectively, of the nuclear re- DOI 10.3858/emm.2010.42.11.074 ceptor target genes through functional cross-talk be- tween ER and the corresponding nuclear receptors. Accepted 14 September 2010 Available Online 27 September 2010 Keywords: constitutive androstane receptor; estro- gen; liver X receptor; phenobarbital; pregnane X re- Abbreviations: CAR, constitutive androstane receptor; CYP, cyto- ceptor; transcriptional activation chrome P450 gene; E2, 17-β estradiol; ER, estrogen receptor; ERE, estrogen response element; GRIP, glucocorticoid receptor interacting protein; LRH, liver receptor homolog; LXR, liver X receptor; LXREs, LXR response elements; MoxE2, moxestrol; PB, Introduction phenobarbital; PBRU, phenobarbital-responsive enhancer; PPAR, Estrogen plays important biological functions not peroxisome proliferator activated receptor; RXR, retinoid X receptor; only in the development of female reproduction SRC, steroid hormone receptor coactivator; SXR, steroid and and cellular proliferation but also in lipid meta- xenobiotic receptor; TCPOBOP, 1,4-bis-(2-(3,5-dichloropyridoxyl)) bolism and biological homeostasis in different tis- benzene sues of body (Archer et al., 1986; Croston et al., 1997; Blum and Cannon, 2001; Deroo and Korach, 2006; Glass, 2006).
    [Show full text]
  • Retinoid X Receptor Α Controls Innate Inflammatory Responses Through The
    Retinoid X receptor α controls innate inflammatory responses through the up-regulation of chemokine expression Vanessa Núñeza,1, Daniel Alamedaa,1, Daniel Ricoa,2, Rubén Motab, Pilar Gonzalob, Marta Cedenillaa, Thierry Fischerc, Lisardo Boscád, Christopher K. Glasse, Alicia G. Arroyob, and Mercedes Ricotea,3 Departments of aRegenerative Cardiology and bVascular Biology and Inflammation, Centro Nacional de Investigaciones Cardiovasculares, Madrid 28029, Spain; cDepartment of Immunology and Oncology, Centro Nacional de Biotecnología, Madrid 28049, Spain; dInstituto de Investigaciones Biomédicas “Alberto Sols” (CSIC-UAM), Madrid 28029, Spain; and eDepartment of Medicine, Department of Cellular and Molecular Medicine, University of California, La Jolla, CA 92093 Edited* by Daniel Steinberg, University of California, La Jolla, CA, and approved April 19, 2010 (received for review November 25, 2009) The retinoid X receptor α (RXRα) plays a central role in the regulation Chemokines and their receptors have been implicated in the of many intracellular receptor signaling pathways and can mediate modulation of leukocyte trafficking, immune/inflammatory respon- ligand-dependent transcription by forming homodimers or hetero- ses, sepsis, and multiorgan failure (18, 19). Clinical studies have also dimers with other nuclear receptors. Although several members of identified elevated levels of chemokines associated with human the nuclear hormone receptor superfamily have emerged as impor- sepsis and acute lung injury (20). tant regulators of macrophage gene expression, the existence in vivo We have examined the role of RXRα in the innate immune of an RXR signaling pathway in macrophages has not been estab- system by conditionally disrupting RXRα in myeloid cells. We lished. Here, we provide evidence that RXRα regulates the transcrip- show that chemokines Ccl6 and Ccl9 are novel target genes for tion of the chemokines Ccl6 and Ccl9 in macrophages independently RXRα in primary peritoneal macrophages.
    [Show full text]
  • Role of Ppars and Retinoid X Receptors in the Regulation of Lung Maturation and Development
    Hindawi Publishing Corporation PPAR Research Volume 2007, Article ID 91240, 8 pages doi:10.1155/2007/91240 Review Article Role of PPARs and Retinoid X Receptors in the Regulation of Lung Maturation and Development Dawn M. Simon1 and Thomas J. Mariani2 1 Division of Pulmonology, Allergy/Immunology, Cystic Fibrosis and Sleep, Department of Pediatrics, School of Medicine, Emory University, Atlanta, GA 30322, USA 2 Division of Pulmonary Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115, USA Received 6 March 2007; Accepted 9 May 2007 Recommended by Theodore J. Standiford Understanding lung development has significant importance to public health because of the fact that interruptions in the normal developmental processes can have prominent effects on childhood and adult lung health. It is widely appreciated that the retinoic acid (RA) pathway plays an important role in lung development. Additionally, PPARs are believed to partner with receptors of this pathway and therefore could be considered extensions of retinoic acid function, including during lung development. This review will begin by introducing the relationship between the retinoic acid pathway and PPARs followed by an overview of lung development stages and regulation to conclude with details on PPARs and the retinoic acid pathway as they may relate to lung development. Copyright © 2007 D. M. Simon and T. J. Mariani. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. 1. THE RETINOIC ACID PATHWAY AND PPAR thermore, nongenomic functions of PPARs upon gene regu- lation (e.g., regulatory effects independent of PPRE binding) The effects of retinoic acid are mediated by the retinoic acid have been reported [3–5].
    [Show full text]
  • Retinoid X Receptors: X-Ploring Their (Patho)Physiological Functions
    Cell Death and Differentiation (2004) 11, S126–S143 & 2004 Nature Publishing Group All rights reserved 1350-9047/04 $30.00 www.nature.com/cdd Review Retinoid X receptors: X-ploring their (patho)physiological functions A Szanto1, V Narkar2, Q Shen2, IP Uray2, PJA Davies2 and aspects of metabolism. The discovery of retinoid receptors L Nagy*,1 substantially contributed to understanding how these small, lipophilic molecules, most importantly retinoic acid (RA), exert 1 Department of Biochemistry and Molecular Biology, Research Center for their pleiotropic effects.1,2 Retinoid receptors belong to the Molecular Medicine, University of Debrecen, Medical and Health Science family of nuclear hormone receptors, which includes steroid Center, Nagyerdei krt. 98, Debrecen H-4012, Hungary 2 hormone, thyroid hormone and vitamin D receptors, various Department of Integrative Biology and Pharmacology, The University of Texas- orphan receptors and also receptors activated by intermediary Houston Medical School, Houston, TX, USA * Corresponding author: L Nagy, Department of Biochemistry and Molecular metabolites: for example, peroxisome proliferator-activated Biology, University of Debrecen, Medical and Health Science Center, receptor (PPAR) by fatty acids, liver X receptor (LXR) by Nagyerdei krt. 98, Debrecen H-4012, Hungary. Tel: þ 36-52-416432; cholesterol metabolites, farnesoid X receptor (FXR) by bile Fax: þ 36-52-314989; E-mail: [email protected] acids and pregnane X receptor (PXR) by xenobiotics.3,4 Members of this family function as ligand-activated
    [Show full text]
  • Retinoid X Receptor and Peroxisome Proliferator-Activated Receptor-Gamma Agonists Cooperate to Inhibit Matrix Metalloproteinase Gene Expression
    Dartmouth College Dartmouth Digital Commons Dartmouth Scholarship Faculty Work 12-1-2008 Retinoid X Receptor and Peroxisome Proliferator-Activated Receptor-Gamma Agonists Cooperate to Inhibit Matrix Metalloproteinase Gene Expression Peter S. Burrage Dartmouth College Adam C. Schmucker Dartmouth College Yanqing Ren Dartmouth College Michael B. Sporn Dartmouth College Constance E. Brinckerhoff Dartmouth College Follow this and additional works at: https://digitalcommons.dartmouth.edu/facoa Part of the Genetic Processes Commons, Medical Biochemistry Commons, and the Rheumatology Commons Dartmouth Digital Commons Citation Burrage, Peter S.; Schmucker, Adam C.; Ren, Yanqing; Sporn, Michael B.; and Brinckerhoff, Constance E., "Retinoid X Receptor and Peroxisome Proliferator-Activated Receptor-Gamma Agonists Cooperate to Inhibit Matrix Metalloproteinase Gene Expression" (2008). Dartmouth Scholarship. 512. https://digitalcommons.dartmouth.edu/facoa/512 This Article is brought to you for free and open access by the Faculty Work at Dartmouth Digital Commons. It has been accepted for inclusion in Dartmouth Scholarship by an authorized administrator of Dartmouth Digital Commons. For more information, please contact [email protected]. Available online http://arthritis-research.com/content/10/6/R139 ResearchVol 10 No 6 article Open Access Retinoid X receptor and peroxisome proliferator-activated receptor-gamma agonists cooperate to inhibit matrix metalloproteinase gene expression Peter S Burrage1*, Adam C Schmucker1*, Yanqing
    [Show full text]